title: Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril.
authors.affiliation: Département de Pharmacologie Clinique, Hôpital Broussais, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Kreft-Jais
authors.forename: P F
authors.initials: PF
authors.lastname: Plouin
authors.forename: C
authors.initials: C
authors.lastname: Tchobroutsky
authors.forename: M J
authors.initials: MJ
authors.lastname: Boutroy
mesh_terms: D000022:Abortion, Spontaneous; D002216:Captopril / Q000009:adverse effects*; D004374:Ductus Arteriosus, Patent / Q000139:chemically induced; D004656:Enalapril / Q000009:adverse effects*; D005260:Female; D005313:Fetal Death; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D007752:Obstetric Labor, Premature; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011263:Pregnancy Trimester, Third
chemical_list: D004656:Enalapril; D002216:Captopril